Maladies peptiques [Acid related diseases progress in 2007].

Details

Serval ID
serval:BIB_413B6D610D71
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Maladies peptiques [Acid related diseases progress in 2007].
Journal
Revue Médicale Suisse
Author(s)
Vouillamoz D., Jornod P., Viani F., Nichita C., Dorta G.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
2008
Volume
4
Number
141
Pages
190-194
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Abstract
The treatment of reflux disease did not changed. PPI treatment remains the first line treatment and surgery a second line treatment. The effect of surgery in reflux disease reduces and, after ten years, a part of the operated patients needs PPI again. The triple therapy is the treatment of choice of Helicobacter pylori infection. Patients with persistent Helicobacter pylori infection, after a first treatment, should be treated with a sequential treatment. PPI are effective in the prevention of gastroduodenal lesions and in the treatment of dyspeptic symptoms during NSAID treatment. IPP should be given to all patients presenting dyspeptic symptoms under NSAID or COX-2 administration.
Keywords
Esophagitis, Peptic/drug therapy, Esophagitis, Peptic/therapy, Gastroesophageal Reflux/drug therapy, Gastroesophageal Reflux/therapy, Helicobacter Infections/drug therapy, Helicobacter pylori, Humans, Stomach Diseases/drug therapy, Stomach Diseases/microbiology
Pubmed
Create date
02/03/2009 13:47
Last modification date
20/08/2019 13:41
Usage data